Show simple item record

dc.creatorAGUILAR,LORENA
dc.creatorRAMÍREZ,GALIA
dc.creatorVALCK,CAROLINA
dc.creatorMOLINA,MARÍA C
dc.creatorROJAS,ÁLVARO
dc.creatorSCHWAEBLE,WILHELM
dc.creatorFERREIRA,VIVIANA
dc.creatorFERREIRA,ARTURO
dc.date2005-01-01
dc.date.accessioned2019-05-02T21:21:25Z
dc.date.available2019-05-02T21:21:25Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-97602005000200008
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/81589
dc.descriptionTrypanosoma cruzi calreticulin (TcCRT), described in our laboratory, retains several important functional features from its vertebrate homologues. We have shown that recombinant TcCRT inhibits the human complement system when it binds to the collagenous portion of C1q. The generation of classical pathway convertases and membrane attack complexes is thus strongly inhibited. In most T. cruzi-infected individuals, TcCRT is immunogenic and mediates the generation of specific antibodies. By reverting the C1q / TcCRT interaction, a parasite immune evasion strategy, these antibodies contribute to the host / parasite equilibrium. In an in vitro correlate of this situation, we show that the C1q / TcCRT interaction is inhibited by F(ab')2 polyclonal anti-TcCRT IgG fragments. It is therefore feasible that in infected humans anti-TcCRT antibodies participate in reverting an important parasite strategy aimed at inhibiting the classical complement pathway. Thus, membrane-bound TcCRT interacts with the collagenous portion C1q, and this C1q is recognized by the CD91-bound host cell CRT, thus facilitating parasite internalization. Based on our in vitro results, it could be proposed that the in vivo interaction between TcCRT and vertebrate C1q could be inhibited by F(ab')2 fragments anti-rTcCRT or against its S functional domain, thus interfering with the internalization process
dc.formattext/html
dc.languageen
dc.publisherSociedad de Biología de Chile
dc.relation10.4067/S0716-97602005000200008
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceBiological Research v.38 n.2-3 2005
dc.subjectcalreticulin
dc.subjectC1q
dc.subjectF(ab')2 antibody fragments
dc.subjectTrypanosoma cruzi
dc.titleF(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement


This item appears in the following Collection(s)

Show simple item record